Maureen P M H Rutten-van Mölken (Maureen Rutten-van Molken, Maureen Rutten-van Mölken, Maureen Rutten-Van Mölken, Maureen Rutten-van Mölken)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Topics

Pain Management

Polycyclic Aromatic Hydrocarbons

Community Dwelling

Health Insurance

Top Venues

Personalized medicine

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Elise van Mulligen, Sterre S Bour, Lucas M A Goossens, Pascal Hendrik Pieter de Jong, Maureen P M H Rutten-van Mölken, Annette H M van der Helm van Mil
Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial. Annals of the rheumatic diseases (2024)
Sterre S Bour, Lena H A Raaijmakers, Erik Wiely Maria Anton Bischoff, Lucas M A Goossens, Maureen P M H Rutten-van Mölken
How Can a Bundled Payment Model Incentivize the Transition from Single-Disease Management to Person-Centred and Integrated Care for Chronic Diseases in the Netherlands? International journal of environmental research and public health 20 (5) (2023)
Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Sarah Wordsworth, Apostolos Tsiachristas
Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK. Personalized medicine (2023)
László Szilberhorn, Tamás Zelei, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Balázs Nagy
Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries. Personalized medicine (2023)
Gábor Kovács, Dávid Nagy, László Szilberhorn, Tamás Zelei, Zsolt Gaál, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Balázs Nagy
Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young. Personalized medicine (2023)
Balázs Nagy, Tamás Zelei, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, László Szilberhorn
Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies. Personalized medicine (2023)
Rositsa Koleva-Kolarova, László Szilberhorn, Tamás Zelei, Heleen Vellekoop, Balázs Nagy, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, Sarah Wordsworth, Apostolos Tsiachristas
Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation. Personalized medicine (2023)
Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, László Szilberhorn, Tamás Zelei, Balázs Nagy, Rositsa Koleva-Kolarova, Sarah Wordsworth, Maureen P M H Rutten-van Mölken, null null
Cost-effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries. Personalized medicine (2023)
Ian P Smith, Chiara L Whichello, Esther Wilhelmina de Bekker-Grob, Maureen P M H Rutten-van Mölken, Jorien Veldwijk, G Ardine de Wit
The Impact of Video-Based Educational Materials with Voiceovers on Preferences for Glucose Monitoring Technology in Patients with Diabetes: A Randomised Study. The patient (2023)
Rositsa Koleva-Kolarova, Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, Maureen P M H Rutten-van Mölken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Sarah Wordsworth, Apostolos Tsiachristas
Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in three health systems. Personalized medicine (2023)
Sterre S Bour, Lena H A Raaijmakers, Erik Wiely Maria Anton Bischoff, Lucas M A Goossens, Maureen P M H Rutten-van Mölken
How Can a Bundled Payment Model Incentivize the Transition from Single-Disease Management to Person-Centred and Integrated Care for Chronic Diseases in the Netherlands? International journal of environmental research and public health 20 (5) (2023)
Sterre S Bour, Lena H A Raaijmakers, Erik Wiely Maria Anton Bischoff, Lucas M A Goossens, Maureen P M H Rutten-van Mölken
How Can a Bundled Payment Model Incentivize the Transition from Single-Disease Management to Person-Centred and Integrated Care for Chronic Diseases in the Netherlands? International journal of environmental research and public health 20 (5) (2023)
Maureen P M H Rutten-van Mölken, Matthijs M Versteegh, Balázs Nagy, Sarah Wordsworth
HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead. Personalized medicine (2023)
Maaike Hoedemakers, Milad Karimi, Fenna Leijten, Lucas Goossens, Kamrul Islam, Apostolos Tsiachristas, Maureen P M H Rutten-van Mölken
Value-based person-centred integrated care for frail elderly living at home: a quasi-experimental evaluation using multicriteria decision analysis. BMJ open 12 (4) (2022)
Fernando Albuquerque de Almeida, Isaac Corro Ramos, Maiwenn Al, Maureen P M H Rutten-van Mölken
Home Telemonitoring and a Diagnostic Algorithm in the Management of Heart Failure in the Netherlands: Cost-effectiveness Analysis. JMIR cardio 6 (2) (2022)
Maureen P M H Rutten-van Mölken, Elisabeth Sophia Hartgers-Gubbels, Michael Chambers
Value Insider Season 1 Episode 4: How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]. International journal of general medicine 15 (2022)
János György Pitter, Mariann Moizs, Éva Somogyiné Ezer, Gábor Lukács, Annamária Szigeti, Imre Repa, Marcell Csanádi, Maureen P M H Rutten-van Mölken, Kamrul Islam, Zoltán Kaló, Zoltán Vokó
Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control. PloS one 17 (10) (2022)
Martine Hoogendoorn, Isaac Corro Ramos, Stéphane Soulard, Jennifer Cook, Erkki Soini, Emma Paulsson, Maureen P M H Rutten-van Mölken
Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study. BMJ open 11 (8) (2021)
Heleen Vellekoop, Simone A Huygens, Matthijs M Versteegh, László Szilberhorn, Tamás Zelei, Balázs Nagy, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Maureen P M H Rutten-van Mölken, null null
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine. PharmacoEconomics 39 (7) (2021)
Marcel F Jonker, Esther Wilhelmina de Bekker-Grob, Jorien Veldwijk, Lucas M A Goossens, Sterre S Bour, Maureen P M H Rutten-van Mölken
COVID-19 Contact Tracing Apps: Predicted Uptake in the Netherlands Based on a Discrete Choice Experiment. JMIR mHealth and uHealth 8 (10) (2020)
Yi Hsuan Chen, Milad Karimi, Maureen P M H Rutten-van Mölken
The disease burden of multimorbidity and its interaction with educational level. PloS one 15 (12) (2020)
Maureen P M H Rutten-van Mölken, Milad Karimi, Fenna Leijten, Maaike Hoedemakers, Willemijn Looman, Kamrul Islam, Jan E Askildsen, Markus Kraus, Darija Ercevic, Verena Struckmann, János Gyorgy Pitter, Isaac Cano, Jonathan Stokes, Marcel Jonker, null null
Comparing patients' and other stakeholders' preferences for outcomes of integrated care for multimorbidity: a discrete choice experiment in eight European countries. BMJ open 10 (10) (2020)
Erik Baltaxe, Thomas Czypionka, Markus Kraus, Miriam Reiss, Jan Erik Askildsen, Renata Grenkovic, Tord Skogedal Lindén, János György Pitter, Maureen P M H Rutten-van Mölken, Oscar Solans Fernández, Jonathan Stokes, Verena Struckmann, Josep Roca, Isaac Cano
Digital Health Transformation of Integrated Care in Europe: Overarching Analysis of 17 Integrated Care Programs. Journal of medical Internet research 21 (9) (2019)
Maureen P M H Rutten-van Mölken, Fenna Leijten, Maaike Hoedemakers, Apostolos Tsiachristas, Nick Verbeek, Milad Karimi, Roland Bal, Antoinette de Bont, Kamrul Islam, Jan Erik Askildsen, Thomas Czypionka, Markus Kraus, Mirjana Huic, János György Pitter, Verena Vogt, Jonathan Stokes, Erik Baltaxe, null null
Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analysis (MCDA). BMC health services research 18 (1) (2018)
Christina Pallitto, Christos Chouaid, Pim Cuijpers, William Dab, Johanna Maria van Dongen, Jaime Espin, Bengt Jönsson, Christian Léonard, David McDaid, Martin Mckee, José Pereira Miguel, Anita Patel, Jean-Yves Reginster, Walter Ricciardi, Maureen P M H Rutten-van Mölken, Valentina Prevolnik Rupel, Tracey H Sach, Franco Sassi, Norman Waugh, Roberto Bertollini
PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION. International journal of technology assessment in health care 33 (6) (2017)